Added to YB: 2025-09-25
Pitch date: 2025-09-23
TEM [bullish]
Tempus AI, Inc.
-16.44%
current return
Author Info
No bio for this author
Company Info
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties.
Market Cap
$12.5B
Pitch Price
$84.50
Price Target
N/A
Dividend
N/A
EV/EBITDA
-82.74
P/E
-59.11
EV/Sales
11.84
Sector
Life Sciences Tools and Services
Category
growth
Tempus AI: deep dive
TEM (strong buy): Healthcare AI platform leveraging genomic testing + EMR data to build precision medicine OS. 288k+ samples sequenced, 40M patient records, 350+ petabytes data. Flywheel: more tests→better AI→more adoption. FY24 rev ~$600M, margins could hit 50%. Risks: founder control, leadership culture, AI washing concerns, execution.
Read full article (32 min)